Chronic responses to direct Ras-targetted therapies

ABSTRACT: To investigate the response of H358 lung cancer cells to long term treatment with a panel of direct Ras and Ras pathway inhibitors. H358 cells harbour a heterozygous G12C mutation of KRAS.

ORGANISM(S): Homo sapiens

PROVIDER: GSE206867 | GEO | 2022/06/27

REPOSITORIES: GEO